Analyst Earnings Forecast Scan: Emergent BioSolutions Inc. (EBS)

Leslie Hanson
January 17, 2018

The stock was sold at an average price of $41.24, for a total transaction of $587,711.24. The company's stock had a trading volume of 322,523 shares, compared to its average volume of 338,150.

Emergent Biosolutions Inc (NYSE:EBS) opened at $47.54 on Tuesday. It has underperformed by 16.70% the S&P500. Its down 23.77% from 1.41M shares previously. With 276,500 avg volume, 2 days are for Mcbc Holdings Incorporated (NASDAQ:MCFT)'s short sellers to cover MCFT's short positions. The SI to Mcbc Holdings Incorporated's float is 3.51%. The stock 0.04% or $0 during the last trading session, reaching $1.61.

Since August 15, 2017, it had 0 insider buys, and 14 selling transactions for $10.03 million activity. Emergent Biosolutions Inc now has $1.97 billion valuation. (NYSE:EBS) to report earnings on February, 22. Emergent Biosolutions's revenue was up 4.6% compared to the same quarter last year. sell-side analysts predict that Emergent Biosolutions Inc will post 1.66 earnings per share for the current fiscal year. EBS's profit will be $24.42 million for 20.69 P/E if the $0.59 EPS becomes a reality. The biopharmaceutical company reported $0.73 EPS for the quarter, beating the Zacks' consensus estimate of $0.41 by $0.32.

Investors sentiment increased to 1.69 in 2017 Q3. Its up 0.25, from 1.1 in 2017Q2. Woodstock Corp who had been investing in Emergent Biosolutions Inc for a number of months, seems to be less bullish one the $2.01B market cap company. Adams Diversified Equity Fund Incorporated holds 17,900 shares. First Allied Advisory Ser Inc accumulated 7,747 shares. California State Teachers Retirement System owned about 0.13% of Emergent Biosolutions worth $2,186,000 at the end of the most recent quarter. Wells Fargo & Mn stated it has 91,136 shares or 0% of all its holdings. Mitsubishi Ufj Secs Hldgs Com holds 1,530 shares or 0.53% of its portfolio. Chardan Capital Markets initiated Emergent BioSolutions Inc. Los Angeles Management And Equity Research reported 26,062 shares or 0.01% of all its holdings. M&T Bank Corp increased its position in shares of Emergent Biosolutions by 1.5% during the 2nd quarter. (NYSE:EBS) shares were sold by Richard Ronald. National Bank & Trust Of Mellon Corp has 554,345 shares for 0.01% of their portfolio. X Communication Ltd Liability Company accumulated 0.03% or 16,196 shares. Sg Americas Securities Limited Liability Corp holds 0% of its portfolio in Emergent BioSolutions Inc. (NYSE:EBS). The Georgia-based Cornercap Investment Counsel has invested 0.25% in Emergent BioSolutions Inc. After $0.73 actual EPS reported by Emergent BioSolutions Inc. for the previous quarter, Wall Street now forecasts -19.18% negative EPS growth. BRONCZEK DAVID J sold $11.89M worth of stock or 46,555 shares. Finally, Chardan Capital upped their price objective on Emergent Biosolutions from $47.00 to $53.00 and gave the stock a "buy" rating in a research note on Tuesday. Therefore 75% are positive.


Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. (NYSE:EBS) rating on Friday, July 14. The stock has "Buy" rating by Singular Research on Monday, March 28. As per Friday, August 7, the company rating was initiated by SunTrust. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). Arizona State Retirement System now owns 18,160 shares of the biopharmaceutical company's stock worth $616,000 after acquiring an additional 100 shares in the last quarter. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. The companyÂ's marketed products include BioThrax, an anthrax vaccine; Anthrasil, a polyclonal antibody for the treatment of inhalational anthrax; BAT for the treatment of botulinum disease; vaccinia immune globulin intravenous that addresses adverse events from smallpox vaccination; reactive skin decontamination lotion kit for the removal or neutralization of chemical warfare agents; and Trobigard, an auto-injector device designed for intramuscular self-injection of atropine sulfate and obidoxime chloride.

Since August 15, 2017, it had 0 buys, and 14 sales for $10.03 million activity. Also, Director Zsolt Harsanyi sold 7,000 shares of Emergent Biosolutions stock in a transaction on Thursday, December 7th. Zacks upgraded Emergent BioSolutions Inc. (NYSE:EBS) shares with value of $386,149 were sold by Hauer Jerome M.

Among 8 analysts covering MCBC Holdings (NASDAQ:MCFT), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 65% are positive. RBC Capital Markets downgraded the shares of IMGN in report on Friday, April 29 to "Sector Perform" rating. The stock has "Buy" rating by Nomura on Wednesday, September 7. (NASDAQ:IMGN) on Wednesday, September 13. The firm earned "Buy" rating on Monday, December 18 by FBR Capital. (NASDAQ:MCFT) on Friday, May 27 with "Buy" rating. On Wednesday, June 21 the stock rating was maintained by Oppenheimer with "Buy". The rating was maintained by MLV with "Buy" on Friday, August 14. The firm has "Buy" rating by Singular Research given on Tuesday, June 28. The stock has "Buy" rating by H.C. Wainwright on Thursday, August 17.

Investors sentiment increased to 2.5 in 2017 Q3. Its up 0.12, from 1.57 in 2017Q2. It is negative, as 0 investors sold comScore, Inc. shares while 8 reduced holdings. 125 funds opened positions while 492 raised stakes. Arrowstreet Partnership invested in 0.02% or 817,616 shares. Ls Advsr Limited Liability Corporation holds 0% or 1,395 shares in its portfolio. (NASDAQ:IMGN) for 43,031 shares. 21,906 Emergent BioSolutions Inc. Sit Investment Assoc reported 0% of its portfolio in comScore, Inc. Morgan Stanley holds 0% of its portfolio in Pluristem Therapeutics Inc. Snyder Ltd Partnership holds 2.22% or 1.10 million shares in its portfolio. The New York-based Blackrock has invested 0% in ImmunoGen, Inc. (NASDAQ:PSTI). Citigroup holds 0% or 1,040 shares. Sio Cap Mgmt Limited Liability Company accumulated 90,268 shares.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER